PICAROS - Acalabrutinib RWE on 1L CLL in Spain

Clinical trial NCT05999877 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05999877
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2023-07-11
Primary completion: 2029-03-31
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.